Heme metabolism of plasmodium is a major antimalarial target.
Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites.
Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Alternative oxidase inhibitors potentiate the activity of atovaquone against Plasmodium falciparum . Cytochrome P450 in parasitic protozoa and helminths. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. Status of Plasmodium falciparum towards catalase.